Company intelligence / Profile preview

Mortimer Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Mortimer Capital is an investment management firm that focuses on the life sciences and healthcare sectors. The firm provides capital and strategic guidance to biotechnology and pharmaceutical companies, often specializing in identifying undervalued assets or high-potential early-stage ventures. Mortimer Capital leverages deep industry expertise to manage portfolios that include both public and private equity investments within the healthcare space. Their business model centers on long-term value creation through active engagement with portfolio companies and rigorous scientific due diligence.

Industry: Investors

Beyond the preview

Go deeper on Mortimer Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mortimer Capital.

Explore the full profile